CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Alectinib

阿来替尼 杂质对照品Alectinib Impurities

43 个杂质条目43 impurity entries

本页汇总 阿来替尼 的 43 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 43 impurity reference standards of Alectinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 阿来替尼(Alectinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesChemometrically assisted optimization and validation of the HPLC method for the analysis of alectinib and its related impurity with measurement uncertainty evaluation and whiteness, blueness, and greenness profile assessments
    BMC chemistry · 2025 · Levent S et al.  ·  PMID 40426245  ·  DOI
  2. 分析方法Analytical MethodsDevelopment of a validated and sensitive ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method to simultaneous determination of crizotinib, alectinib and lorlatinib in human plasma
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2025 · Chi H et al.  ·  PMID 40902417  ·  DOI
  3. 分析方法Analytical MethodsDevelopment and validation of an HPLC-MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run
    Biomedical chromatography : BMC · 2021 · van Veelen A et al.  ·  PMID 34363425  ·  DOI
  4. 分析方法Analytical MethodsCorrection: Integrating analytical quality by design into bioanalytical method development: an HPLC-FLD method for quantification of alectinib in biological matrix
    BMC chemistry · 2026 · Lee EJ et al.  ·  PMID 42850617  ·  DOI
  5. 分析方法Analytical MethodsIntegrating analytical quality by design into bioanalytical method development: an HPLC-FLD method for quantification of alectinib in biological matrix
    BMC chemistry · 2025 · Lee EJ et al.  ·  PMID 40847406  ·  DOI

阿来替尼 —— 原料药与杂质对照品Alectinib — drug substance & impurities

共 44 个条目(含原料药本体)44 items incl. the drug substance
Alectinib structure
原料药 APIAPI
阿来替尼Alectinib
Alectinib
CAS No.1256580-46-7
Chemical FormulaC30H34N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib M4 Metabolite structure
—
盐酸阿来替尼杂质1 (阿来替尼M4代谢物)Alectinib M4 Metabolite
Alectinib M4 Metabolite
CAS No.1256585-04-2
Chemical FormulaC28H32N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib N-Oxide structure
—
盐酸阿来替尼杂质23 (阿来替尼氮氧化物)Alectinib N-Oxide
Alectinib N-Oxide
CAS No.1256585-28-0
Chemical FormulaC30H34N4O3
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Alectinib structure
—
N-Nitroso Alectinib
CAS No.—
Chemical FormulaC30H33N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib M4 Metabolite-d6 structure
—
Alectinib M4 Metabolite-d6
CAS No.—
Chemical FormulaC28H26D6N4O2
Purity>95%询价On request
Alectinib Impurity 2 structure
2
盐酸阿来替尼杂质2Alectinib Impurity 2
Alectinib Impurity 2
CAS No.1256585-14-4
Chemical FormulaC26H28N4O
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 3 structure
3
阿来替尼杂质3Alectinib Impurity 3
Alectinib Impurity 3
CAS No.—
Chemical FormulaC30H34N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 4 structure
4
阿来替尼杂质4Alectinib Impurity 4
Alectinib Impurity 4
CAS No.—
Chemical FormulaC30H34N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 5 Trifluoroacetate structure
5
阿来替尼杂质5Alectinib Impurity 5 Trifluoroacetate
Alectinib Impurity 5 Trifluoroacetate
CAS No.—
Chemical FormulaC30H36N4O3.C2HF3O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 6 structure
6
盐酸阿来替尼杂质9Alectinib Impurity 6
Alectinib Impurity 6
CAS No.1256584-78-7
Chemical FormulaC30H36N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 7 structure
7
盐酸阿来替尼杂质22Alectinib Impurity 7
Alectinib Impurity 7
CAS No.1256584-79-8
Chemical FormulaC30H34N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 8 structure
8
盐酸阿来替尼杂质19Alectinib Impurity 8
Alectinib Impurity 8
CAS No.1256585-32-6
Chemical FormulaC30H33N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 9 structure
9
盐酸阿来替尼杂质8Alectinib Impurity 9
Alectinib Impurity 9
CAS No.1256585-29-1
Chemical FormulaC25H26INO3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 10 structure
10
阿来替尼杂质10Alectinib Impurity 10
Alectinib Impurity 10
CAS No.—
Chemical FormulaC30H36N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 11 structure
11
盐酸阿来替尼杂质28Alectinib Impurity 11
Alectinib Impurity 11
CAS No.2287185-55-9
Chemical FormulaC25H27IN2O5
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 12 structure
12
阿来替尼杂质12Alectinib Impurity 12
Alectinib Impurity 12
CAS No.—
Chemical FormulaC25H29IN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 13 Sodium Salt structure
13
阿来替尼杂质13Alectinib Impurity 13 Sodium Salt
Alectinib Impurity 13 Sodium Salt
CAS No.—
Chemical FormulaC30H33N4O5S.Na
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 14 structure
14
阿来替尼杂质14Alectinib Impurity 14
Alectinib Impurity 14
CAS No.—
Chemical FormulaC25H29IN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 15 structure
15
阿来替尼杂质15Alectinib Impurity 15
Alectinib Impurity 15
CAS No.—
Chemical FormulaC25H27IN2O4
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 16 structure
16
盐酸阿来替尼杂质7 单体Alectinib Impurity 16
Alectinib Impurity 16
CAS No.1256698-41-5
Chemical FormulaC34H44N4O3
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Alectinib Impurity 16 structure
16
N-Nitroso Alectinib Impurity 16
CAS No.—
Chemical FormulaC34H43N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 17 structure
17
盐酸阿来替尼杂质46Alectinib Impurity 17
Alectinib Impurity 17
CAS No.1820882-01-6
Chemical FormulaC29H36N4O
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 18 structure
18
阿来替尼杂质18Alectinib Impurity 18
Alectinib Impurity 18
CAS No.—
Chemical FormulaC30H35N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 19 structure
19
阿来替尼杂质19Alectinib Impurity 19
Alectinib Impurity 19
CAS No.—
Chemical FormulaC30H36N4O3
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Alectinib Impurity 19 structure
19
N-Nitroso Alectinib Impurity 19
CAS No.—
Chemical FormulaC30H36N4O3
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Alectinib Impurity 20 structure
20
盐酸阿来替尼杂质49 (N-亚硝基盐酸阿来替尼杂质32)N-Nitroso Alectinib Impurity 20
N-Nitroso Alectinib Impurity 20
CAS No.2089333-06-0
Chemical FormulaC9H17N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 20 DiHCl structure
20
盐酸阿来替尼杂质32 双盐酸盐Alectinib Impurity 20 DiHCl
Alectinib Impurity 20 DiHCl
CAS No.334942-10-8
Chemical FormulaC9H20Cl2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 21 structure
21
盐酸阿来替尼杂质6Alectinib Impurity 21
Alectinib Impurity 21
CAS No.1256584-75-4
Chemical FormulaC25H27IN2O2
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Alectinib Impurity 21 structure
21
N-Nitroso Alectinib Impurity 21
CAS No.—
Chemical FormulaC25H26IN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 23 structure
23
盐酸阿来替尼杂质69Alectinib Impurity 23
Alectinib Impurity 23
CAS No.125541-20-0
Chemical FormulaC14H26N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 24 structure
24
盐酸阿来替尼杂质14Alectinib Impurity 24
Alectinib Impurity 24
CAS No.1256584-73-2
Chemical FormulaC12H15IO2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 25 structure
25
盐酸阿来替尼杂质34Alectinib Impurity 25
Alectinib Impurity 25
CAS No.2412921-44-7
Chemical FormulaC25H28N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 2-d6 structure
2-D6
阿来替尼杂质2Alectinib Impurity 2-d6
Alectinib Impurity 2-d6
CAS No.—
Chemical FormulaC26H22D6N4O
Purity>95%询价On request
Alectinib Impurity 26 structure
26
阿来替尼杂质26Alectinib Impurity 26
Alectinib Impurity 26
CAS No.3105679-59-9
Chemical FormulaC51H51N7O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 27 structure
27
盐酸阿来替尼杂质11Alectinib Impurity 27
Alectinib Impurity 27
CAS No.1256584-83-4
Chemical FormulaC26H25N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 28 structure
28
阿来替尼杂质28Alectinib Impurity 28
Alectinib Impurity 28
CAS No.1256584-54-9
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 29 structure
29
盐酸阿来替尼杂质10Alectinib Impurity 29
Alectinib Impurity 29
CAS No.1256584-81-2
Chemical FormulaC28H29N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 30 structure
30
阿来替尼杂质30Alectinib Impurity 30
Alectinib Impurity 30
CAS No.—
Chemical FormulaC34H44N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 31 structure
31
阿来替尼杂质31Alectinib Impurity 31
Alectinib Impurity 31
CAS No.—
Chemical FormulaC30H36N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 32 structure
32
阿来替尼杂质32Alectinib Impurity 32
Alectinib Impurity 32
CAS No.2121599-20-8
Chemical FormulaC21H19IN2O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 33 structure
33
阿来替尼杂质33Alectinib Impurity 33
Alectinib Impurity 33
CAS No.—
Chemical FormulaC25H30N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 34 structure
34
盐酸阿来替尼杂质12Alectinib Impurity 34
Alectinib Impurity 34
CAS No.1256584-80-1
Chemical FormulaC21H17IN2O
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 35 Trifluoroacetate structure
35
阿来替尼杂质35Alectinib Impurity 35 Trifluoroacetate
Alectinib Impurity 35 Trifluoroacetate
CAS No.—
Chemical FormulaC32H36N4O3.C2HF3O2
Purity>95%询价On request
10mg25mg50mg100mg
Alectinib Impurity 36 Iodide structure
36
Alectinib Impurity 36 Iodide
CAS No.—
Chemical FormulaC26H22N3O.I
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

阿来替尼 —— 研究文献与合成路线Alectinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 阿来替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Alectinib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK)
    Xie S, Sun Y, Liu Y, et al. · Journal of medicinal chemistry · 2021 · 被引 56cited 56
  2. Structure-based discovery of SIAIS001 as an oral bioavailability ALK degrader constructed from Alectinib
    Ren C, Sun N, Kong Y, et al. · European journal of medicinal chemistry · 2021 · 被引 37cited 37
  3. Exploiting the polypharmacology of alectinib for synergistic RNA splicing disruption with RBM39 degraders
    Ma Y, Poon E, Jin C, et al. · Cell reports · 2026 · 被引 1cited 1
  4. Chemometrically assisted optimization and validation of the HPLC method for the analysis of alectinib and its related impurity with measurement uncertainty evaluation and whiteness, blueness, and greenness profile assessments
    Levent S, Elriş A, Avcı H, et al. · BMC chemistry · 2025 · 被引 1cited 1

合成路线文献Synthetic-route papers

  1. Alectinib Synthesis through Formal α-Arylation of Enone
    Singh S, Yadav A, Tripathi CB · Organic letters · 2025
  2. Alectinib-Loaded Chitosan-Alginate Nanoparticles: A Novel Synthesis Method with In Vitro and In Vivo Evaluations
    Ata T, Al-Ani I, Karameh N, et al. · Pharmaceutics · 2025
  3. Synthesis of Co/Co3O4 Heterostructure in N-Doped Porous, Amorphous Carbon: A Superior Electrochemical Sensor for Sensitive Determination of Alectinib in Various Fluids
    Bugday N, Gabiam EN, Erk N, et al. · ACS omega · 2024

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

阿来替尼 杂质谱研究要点Alectinib — impurity profiling notes

下面这些是拿到 阿来替尼 的 44 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 44 impurity entries for Alectinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances